Model DetailsOviduct hyperplasia
Model Name |
Oviduct hyperplasia | Strain |
CD-1 |
Tumor Inducing Agent(s) |
Hormone : diethylstilbestrol (DES) |
Tumor Synonyms |
oviduct hyperplasia • progressive proliferative lesion of the oviduct (PPL) |
Strain Synonyms |
outbred CD-1 • Swiss CD-1® • CD1 nontransgenic • Charles River CD-1 • Swiss CD-1 • Crl:CD-1®(ICR) • outbred CD1 • (Swiss) CD-1 • CD1 • Crl:CD-1(ICR)BR • ICR Crj:CD-1 • random-bred Crl:CD-1(ICR)BR • CD-1 outbred • Crl:CD-1 (ICR) BR • Crj:CD-1(ICR) • ICR(CD-1) • Crl: CD-1 (ICR) BR • ICR |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Oviduct | Female |
36% (10 of 28 mice) |
22-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Oviduct | Female |
16% (5 of 32 mice) |
22-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Oviduct | Female |
44% (7 of 16 mice) |
17-19 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Oviduct | Female |
14% (3 of 22 mice) |
22-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Oviduct | Female |
33% (5 of 15 mice) |
22-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Oviduct | Female |
21% (7 of 34 mice) |
22-24 months |
|
Newbold RR, Carcinogenesis 1998 Sep;19(9):1655-63 |
| Oviduct | Female |
73% (24 of 33 mice) |
90 weeks |
|
Waalkes MP, Cancer Res 2006 Feb 1;66(3):1337-45 |